AI assistant
DEXCOM INC — Director's Dealing 2017
Jan 20, 2017
30198_dirs_2017-01-20_9714bef8-6cd4-478d-8fef-7b7ae791625b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2017-01-18
Reporting Person: ROPER JESS (SVP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-18 | Common Stock | S | 3012 | $85.0102 | Disposed | 12785 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 55976 | Direct |
Footnotes
F1: On November 04, 2016, Mr. Roper adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Roper. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: This transaction was executed in multiple trades at prices ranging from 84.39 to 85.97. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: Shares are held by the LJR Family Trust U/T/A DTD 08/08/2013, with respect to which the reporting person is a trustee.